Literature DB >> 26781426

External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.

Neil K Taunk1, Fabio Y Moraes2, Freddy E Escorcia1, Lucas Castro Mendez3, Kathryn Beal1, Gustavo N Marta2,4.   

Abstract

Glioblastoma is a common aggressive primary malignant brain tumor, and is nearly universal in progression and mortality after initial treatment. Re-irradiation presents a promising treatment option for progressive disease, both palliating symptoms and potentially extending survival. Highly conformal radiation techniques such as stereotactic radiosurgery and hypofractionated radiosurgery are effective short courses of treatment that allow delivery of high doses of therapeutic radiation with steep dose gradients to protect normal tissue. Patients with higher performance status, younger age, and longer interval between primary treatment and progression represent the best candidates for re-irradiation. Multiple studies are also underway involving combinations of radiation and systemic therapy to bend the survival curve and improve the therapeutic index. In the multimodal treatment of recurrent high-grade glioma, the use of surgery, radiation, and systemic therapy should be highly individualized. Here we comprehensively review radiation therapy and techniques, along with discussion of combination treatment and novel strategies.

Entities:  

Keywords:  Radiation therapy; glioblastoma; high grade glioma; stereotactic radiosurgery

Mesh:

Year:  2016        PMID: 26781426      PMCID: PMC4998049          DOI: 10.1586/14737140.2016.1143364

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  62 in total

1.  Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.

Authors:  Robert E Elliott; Erik C Parker; Stephen C Rush; Stephen P Kalhorn; Yaron A Moshel; Ashwatha Narayana; Bernadine Donahue; John G Golfinos
Journal:  World Neurosurg       Date:  2011 Jul-Aug       Impact factor: 2.104

2.  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

Authors:  Roger Stupp; Eric T Wong; Andrew A Kanner; David Steinberg; Herbert Engelhard; Volkmar Heidecke; Eilon D Kirson; Sophie Taillibert; Frank Liebermann; Vladimir Dbalý; Zvi Ram; J Lee Villano; Nikolai Rainov; Uri Weinberg; David Schiff; Lara Kunschner; Jeffrey Raizer; Jerome Honnorat; Andrew Sloan; Mark Malkin; Joseph C Landolfi; Franz Payer; Maximilian Mehdorn; Robert J Weil; Susan C Pannullo; Manfred Westphal; Martin Smrcka; Lawrence Chin; Herwig Kostron; Silvia Hofer; Jeffrey Bruce; Rees Cosgrove; Nina Paleologous; Yoram Palti; Philip H Gutin
Journal:  Eur J Cancer       Date:  2012-05-18       Impact factor: 9.162

3.  Extended field stereotactic radiosurgery for recurrent glioblastoma.

Authors:  Tomoyuki Koga; Keisuke Maruyama; Minoru Tanaka; Yasushi Ino; Nobuhito Saito; Keiichi Nakagawa; Junji Shibahara; Tomoki Todo
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

4.  A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.

Authors:  Wolfgang Wick; Harald Fricke; Klaus Junge; Grigory Kobyakov; Tobias Martens; Oliver Heese; Benedikt Wiestler; Maximilian G Schliesser; Andreas von Deimling; Josef Pichler; Elena Vetlova; Inga Harting; Jürgen Debus; Christian Hartmann; Claudia Kunz; Michael Platten; Martin Bendszus; Stephanie E Combs
Journal:  Clin Cancer Res       Date:  2014-10-22       Impact factor: 12.531

5.  Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme.

Authors:  S E Combs; S Gutwein; Ch Thilmann; P Huber; J Debus; D Schulz-Ertner
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 6.  Recurrent glioblastoma multiforme: a review of natural history and management options.

Authors:  Lewis C Hou; Anand Veeravagu; Andrew R Hsu; Victor C K Tse
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

7.  Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

Authors:  Stephanie E Combs; Christoph Thilmann; Lutz Edler; Jürgen Debus; Daniela Schulz-Ertner
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

8.  Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study).

Authors:  R W Laing; A P Warrington; J Graham; J Britton; F Hines; M Brada
Journal:  Radiother Oncol       Date:  1993-04       Impact factor: 6.280

9.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

Review 10.  Combining angiogenesis inhibition and radiotherapy: a double-edged sword.

Authors:  Esther A Kleibeuker; Arjan W Griffioen; Henk M Verheul; Ben J Slotman; Victor L Thijssen
Journal:  Drug Resist Updat       Date:  2012-05-04       Impact factor: 18.500

View more
  14 in total

1.  Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

Authors:  Pierina Navarria; Giuseppe Minniti; Elena Clerici; Stefano Tomatis; Valentina Pinzi; Patrizia Ciammella; Marco Galaverni; Dante Amelio; Daniele Scartoni; Silvia Scoccianti; Marco Krengli; Laura Masini; Lorena Draghini; Ernesto Maranzano; Valentina Borzillo; Paolo Muto; Fabio Ferrarese; Laura Fariselli; Lorenzo Livi; Francesco Pasqualetti; Alba Fiorentino; Filippo Alongi; Michela Buglione di Monale; Stefano Magrini; Marta Scorsetti
Journal:  J Neurooncol       Date:  2018-12-04       Impact factor: 4.130

Review 2.  How We Treat Recurrent Glioblastoma Today and Current Evidence.

Authors:  Caroline Chaul-Barbosa; Daniel Fernandes Marques
Journal:  Curr Oncol Rep       Date:  2019-10-12       Impact factor: 5.075

3.  Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.

Authors:  Jennifer Clarke; Elizabeth Neil; Robert Terziev; Philip Gutin; Igor Barani; Thomas Kaley; Andrew B Lassman; Timothy A Chan; Josh Yamada; Lisa DeAngelis; Ase Ballangrud; Robert Young; Katherine S Panageas; Kathryn Beal; Antonio Omuro
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-30       Impact factor: 7.038

4.  Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.

Authors:  Hideki Kashiwagi; Shinji Kawabata; Kohei Yoshimura; Yusuke Fukuo; Takuya Kanemitsu; Koji Takeuchi; Ryo Hiramatsu; Kai Nishimura; Kazuki Kawai; Takushi Takata; Hiroki Tanaka; Tsubasa Watanabe; Minoru Suzuki; Shin-Ichi Miyatake; Hiroyuki Nakamura; Masahiko Wanibuchi
Journal:  Invest New Drugs       Date:  2021-11-24       Impact factor: 3.651

Review 5.  Preserving the legacy of reirradiation: A narrative review of historical publications.

Authors:  Carsten Nieder; Johannes A Langendijk; Matthias Guckenberger; Anca L Grosu
Journal:  Adv Radiat Oncol       Date:  2017-02-28

6.  Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.

Authors:  Jeongshim Lee; Sung Soo Ahn; Jong Hee Chang; Chang Ok Suh
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

7.  Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).

Authors:  Stephanie E Combs; Maximilian Niyazi; Sebastian Adeberg; Nina Bougatf; David Kaul; Daniel F Fleischmann; Arne Gruen; Emmanouil Fokas; Claus M Rödel; Franziska Eckert; Frank Paulsen; Oliver Oehlke; Anca-Ligia Grosu; Annekatrin Seidlitz; Annika Lattermann; Mechthild Krause; Michael Baumann; Maja Guberina; Martin Stuschke; Volker Budach; Claus Belka; Jürgen Debus; Kerstin A Kessel
Journal:  Cancer Med       Date:  2018-03-23       Impact factor: 4.452

8.  Stereotactic Radiosurgery for the Treatment of Recurrent High-grade Gliomas: Long-term Follow-up.

Authors:  Kita Sallabanda; Loreto Yañez; Morena Sallabanda; Marcos Santos; Felipe A Calvo; Hugo Marsiglia
Journal:  Cureus       Date:  2019-12-31

9.  Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma.

Authors:  Kerstin A Kessel; Josefine Hesse; Christoph Straube; Claus Zimmer; Friederike Schmidt-Graf; Jürgen Schlegel; Bernhard Meyer; Stephanie E Combs
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

10.  Blocking PD1/PDL1 Interactions Together with MLN4924 Therapy is a Potential Strategy for Glioma Treatment.

Authors:  Natalia Filippova; Xiuhua Yang; Zixiao An; Louis B Nabors; Larisa Pereboeva
Journal:  J Cancer Sci Ther       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.